COMMUNIQUÉS West-GlobeNewswire

InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China
07/05/2026
BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock
07/05/2026
SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the pricing of an underwritten public offering of 9,859,155 shares of its common stock at a price [...]
SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support
07/05/2026
SteelPower Male Enhancement Scam Searches, Complaints, Ingredients, Refund Policy, and Pricing Explained for 2026 Aurora, CO, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and [...]
SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
07/05/2026
JERSEY CITY, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) (“SCYNEXIS” or the “Company”), a biotechnology company focused on developing innovative new therapies to address severe rare diseases [...]
Totus Medicines Presents Early Phase 1b Clinical Data Demonstrating 100% Disease Control Rate and Class-Leading Safety for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER2- Breast Cancer at ESMO Breast Cancer Annual Congress 2026
07/05/2026
TOS-358 is a covalent, pan-mutant, a -selective PI3K inhibitor designed to address key limitations of existing PI3K a therapies which include limited mutation coverage and poor tolerability First presentation of [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2026 Financial Results on May 8, 2026
07/05/2026
FREDERICK, Md., May 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]
Memora Claims Evaluated: New Memory Health Report Examines Advanced Brain Health Supplement for Preventing Cognitive Decline
07/05/2026
How Bacopa Monnieri, Lion's Mane, Ginkgo Biloba, Rhodiola Rosea, and Panax Ginseng Support Memory Function and Cognitive Wellness in 2026 Tallmadge, OH, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
InsuLeaf Claims Evaluated: The Safer & More Effective than GLP-1 Drugs, Natural Leak Peak Formula
07/05/2026
How InsuLeaf's Chromium, Alpha Lipoic Acid, Cinnamon, Gymnema sylvestre, and Bitter Melon Blood Sugar Support Formula Compares to GLP-1 Drug Searches in 2026 Largo, FL, May 06, 2026 (GLOBE NEWSWIRE) -- The phrase "safer [...]
Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer
07/05/2026
Data contributed to the scientific and clinical rationale for RASolute 302, a pivotal Phase 3 trial in second line treatment of patients with metastatic pancreatic cancer REDWOOD CITY, Calif., May 06, 2026 (GLOBE [...]
Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
06/05/2026
EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live [...]
Vireo Growth Inc. to Release First Quarter Results on May 12, 2026
06/05/2026
MINNEAPOLIS, May 06, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its first quarter ended March 31, 2026 [...]
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
06/05/2026
Phase 1a interim data for ongoing CTIM-76 (CLDN6 x CD3) trial expected in June 2026 Phase 1a interim data for ongoing CT-95 (MSLN x CD3) trial expected in September 2026 Phase 1 initiation for CT-202 (Nectin-4 x CD3) [...]
Alpha Honey Gummies Claims Evaluated: The AlphaHoney Male Enhancement Ingredients for Virility-Enhancing Performance Support
06/05/2026
How Muira Puama, Maca, Ashwagandha, L-Arginine, and Tribulus Terrestris Work in the AlphaHoney Male Performance Gummy Formula for Libido, Testosterone Support, and Circulation in 2026 Largo, FL, May 06, 2026 (GLOBE [...]
Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026
06/05/2026
LEXINGTON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to [...]
Bionano Announces Leadership Transition
06/05/2026
SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief [...]
Precipio Announces Q1-2026 Shareholder Update Call
06/05/2026
Conference Call will be held on May 18th, 2026, at 5:00 PM EST NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q1-2026 [...]
Gala Health Under Investigation: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support
06/05/2026
Compounded Tirzepatide, Semaglutide, and Bioidentical HRT Telehealth Plans Through Gala GLP-1: Licensed Providers, $149/Mo Pricing, and All-50-States Access Explained for 2026 Wilmington, Delaware, May 06, 2026 (GLOBE [...]
Zelluna ASA activates first clinical site for ZIMA-101, marking entry into clinical execution
06/05/2026
Oslo, 6 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announces that the first [...]
BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand
06/05/2026
Transforms fragmented communication into real-time, AI-driven coordination, assignment, and guided response NETANYA, Israel, May 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE: PHGE) (“BiomX” or the “Company”) today [...]

Pages